Transatlantique Private Wealth LLC Has $1.35 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Transatlantique Private Wealth LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 22.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,663 shares of the healthcare conglomerate’s stock after selling 754 shares during the quarter. Transatlantique Private Wealth LLC’s holdings in UnitedHealth Group were worth $1,347,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of UNH. Howard Capital Management Group LLC acquired a new position in UnitedHealth Group during the third quarter valued at approximately $341,000. Principal Financial Group Inc. lifted its stake in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. M&T Bank Corp increased its stake in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after purchasing an additional 26,074 shares during the last quarter. McIlrath & Eck LLC lifted its stake in UnitedHealth Group by 8.2% in the 3rd quarter. McIlrath & Eck LLC now owns 635 shares of the healthcare conglomerate’s stock valued at $371,000 after purchasing an additional 48 shares during the last quarter. Finally, SOA Wealth Advisors LLC. raised its stake in UnitedHealth Group by 3.7% in the third quarter. SOA Wealth Advisors LLC. now owns 1,275 shares of the healthcare conglomerate’s stock valued at $746,000 after buying an additional 46 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 22.0 %

NYSE UNH opened at $456.10 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $438.50 and a fifty-two week high of $630.73. The stock has a market capitalization of $417.20 billion, a PE ratio of 29.43, a PEG ratio of 1.37 and a beta of 0.61. The business has a fifty day moving average price of $512.95 and a two-hundred day moving average price of $540.29.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the business earned $6.91 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.84%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on UNH shares. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Mizuho upped their target price on UnitedHealth Group from $600.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Finally, Truist Financial upped their price objective on UnitedHealth Group from $610.00 to $660.00 and gave the company a “buy” rating in a report on Friday, April 11th. Twenty-one investment analysts have rated the stock with a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $632.85.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.